Prestige Consumer Healthcare
306 hedge funds and large institutions have $3.51B invested in Prestige Consumer Healthcare in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 118 increasing their positions, 106 reducing their positions, and 36 closing their positions.
588% more call options, than puts
Call options by funds: $330K | Put options by funds: $48K
11% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 106
0.63% less ownership
Funds ownership: 103.38% → 102.75% (-0.63%)
6% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 36
2% less funds holding
Funds holding: 312 → 306 (-6)
6% less capital invested
Capital invested by funds: $3.72B → $3.51B (-$209M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$18.6M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$18.5M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$11.6M |
| 4 |
FMI
F/M Investments
Washington,
District of Columbia
|
+$11M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$9.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
-$32.7M |
| 2 |
BlackRock
New York
|
-$30.9M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.1M |
| 4 |
Morgan Stanley
New York
|
-$9.58M |
| 5 |
JP Morgan Chase
New York
|
-$8.43M |
PBH Hedge Fund Activity: Q2 2024 in Review
306 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2024, worth a combined $3.51B — down 5.6% from $3.72B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of PBH and 34 opened new positions — a net loss of 2 holders — while 106 trimmed existing stakes and 118 added.
The largest buyer was Ariel Investments, adding an estimated $18.6M. The largest seller was Nordea Investment Management, cutting an estimated $32.7M.
- 306 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2024, down from 312 in Q1 2024.
- Funds reported $3.51B of Prestige Consumer Healthcare stock for Q2 2024, down 5.6% quarter-over-quarter.
- 34 funds opened new Prestige Consumer Healthcare positions in Q2 2024 and 36 closed out, a net change of -2 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2024 was Ariel Investments, an estimated $18.6M added.
- The largest Prestige Consumer Healthcare seller in Q2 2024 was Nordea Investment Management, an estimated $32.7M sold.
Based on aggregated 13F filings for Q2 2024.